Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations

[1] Chiorazzi N(2005)Chronic lymphocytic leukemia N Engl J Med 352 804-15

[2] Rai KR(2010)From pathogenesis to treatment of chronic lymphocytic leukaemia Nat Rev Cancer 10 37-50

[3] Ferrarini M(2007)Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997 J Clin Oncol 25 799-804

[4] Zenz T(2015)Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment Am J Hematol 90 446-60

[5] Mertens D(1981)A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Cancer 48 198-206

[6] Küppers R(1999)Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 94 1840-7

[7] Döhner H(2003)ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile Blood 101 4944-51

[8] Stilgenbauer S(2014)CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia J Clin Oncol 32 897-904

[9] Grever MR(1990)Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities N Engl J Med 323 720-4

[10] Lucas DM(2000)Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med 343 1910-6

[1] Chiorazzi N(2005)Chronic lymphocytic leukemia N Engl J Med 352 804-15

[2] Rai KR(2010)From pathogenesis to treatment of chronic lymphocytic leukaemia Nat Rev Cancer 10 37-50

[3] Ferrarini M(2007)Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997 J Clin Oncol 25 799-804

[4] Zenz T(2015)Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment Am J Hematol 90 446-60

[5] Mertens D(1981)A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Cancer 48 198-206

[6] Küppers R(1999)Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 94 1840-7

[7] Döhner H(2003)ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile Blood 101 4944-51

[8] Stilgenbauer S(2014)CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia J Clin Oncol 32 897-904

[9] Grever MR(1990)Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities N Engl J Med 323 720-4

[10] Lucas DM(2000)Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med 343 1910-6